Capping protein increases the rate of actin-based motility by promoting filament nucleation by the Arp2/3 complex.

Department of Cellular and Molecular Pharmacology, School of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.
Cell (Impact Factor: 33.12). 06/2008; 133(5):841-51. DOI: 10.1016/j.cell.2008.04.011
Source: PubMed

ABSTRACT Capping protein (CP) is an integral component of Arp2/3-nucleated actin networks that drive amoeboid motility. Increasing the concentration of capping protein, which caps barbed ends of actin filaments and prevents elongation, increases the rate of actin-based motility in vivo and in vitro. We studied the synergy between CP and Arp2/3 using an in vitro actin-based motility system reconstituted from purified proteins. We find that capping protein increases the rate of motility by promoting more frequent filament nucleation by the Arp2/3 complex and not by increasing the rate of filament elongation as previously suggested. One consequence of this coupling between capping and nucleation is that, while the rate of motility depends strongly on the concentration of CP and Arp2/3, the net rate of actin assembly is insensitive to changes in either factor. By reorganizing their architecture, dendritic actin networks harness the same assembly kinetics to drive different rates of motility.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Depolymerization of actin filaments is vital for the morphogenesis of dynamic cytoskeletal arrays and actin-dependent cell motility. Cofilin is necessary for actin disassembly in cells, and it severs filaments most efficiently at low cofilin to actin ratios, whereas higher concentrations of cofilin suppress severing. However, the cofilin concentration in thymocytes is too high to allow the severing of single-actin filaments. We observed that filaments sever efficiently in thymus cytosol. We identified Aip1 as a critical factor responsible for the severing and destabilization of actin filaments even in the presence of high amounts of cofilin. By fluorescence resonance energy transfer (FRET)-based spectroscopy and single-filament imaging of actin, we show that, besides driving the rapid severing of cofilin-actin filaments, Aip1 also augments the monomer dissociation rate at both the barbed and pointed ends of actin. Our results also demonstrate that Aip1 does not cap the barbed ends of actin filaments, as was previously thought. Our results indicate that Aip1 is a cofilin-dependent actin depolymerization factor and not a barbed-end-capping factor as was previously thought. Aip1 inverts the rules of cofilin-mediated actin disassembly such that increasing ratios of cofilin to actin now result in filament destabilization through faster severing and accelerated monomer loss from barbed and pointed ends. Aip1 therefore offers a potential control point for disassembly mechanisms in cells to switch from a regime of cofilin-saturation and stabilization to one that favors fast disassembly and destabilization. Copyright © 2014 Elsevier Ltd. All rights reserved.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: 350 words maximum: (PLEASE TYPE) The leukocyte immunoglobulin-like receptor (LILR) B4 belongs to a family of activating and inhibitory cell surface receptors that are increasingly recognised as key regulators of leukocyte functions. LILRB4 is an inhibitory molecule that is highly expressed on the surface of monocytes and macrophages. It is believed to inhibit leukocyte activation through the recruitment of phosphatases to its ITIM-containing cytoplasmic tail. However, there is no comprehensive data that elucidate the underlying mechanisms of LILRB4-mediated inhibitory effects and signalling in vitro and in vivo. This is in part due to lack of in depth investigation of the effects of LILRB4 in vitro. The first part of the project showed that LILRB4 is a potent inhibitor of FcγRI-mediated TNFα production in monocyte. Furthermore, LILRB4 was shown to selectively down-regulate key protein tyrosine kinases such Lck, Syk, LAT and Erk that are involved in the secretory functions of monocytes, but not the cytoskeletal protein α-actinin-4. Furthermore, this study is the first to shows that LILRB4 utilise multiple phosphatases including a novel SHP-1-like phosphatase for its inhibitory functions.
  • Source

Full-text (2 Sources)

Available from
May 26, 2014